PLX023761

GSE117596: PRMT5 knockdown changes gene expression in prostate cancer cells

• Organsim human
• Type RNASEQ
• Target gene
• Project ARCHS4

PRMT5 is the major type II protein arginine methyltransferase catalyzing the symmetric dimethylation of arginine. Recent reports have indicated that PRMT5 is overexpressed in multiple cancer types, including prostate. However, the exact contribution of PRMT5 to prostate tumorigenesis is unknown. To explore the functional role of PRMT5 in prostate cancer (PCa), we knocked down PRMT5 by lentiviral shRNAs in both AR-dependent LNCaP cells and AR-independent PC3 cells. Our data suggests that PRMT5 regulates PCa cell biology. To further identify PRMT5-regulated genes in PCa, we performed paired-end RNA-seq analysis in PC3 and LNCaP cells with or without PRMT5-knockdown. SOURCE: Dingxiao Zhang (Dingxiao.Zhang@Roswellpark.org) - Tang lab Roswell Park Cancer Institute